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The Blue Man
Amiodarone-Induced Skin Discoloration
Frank Enseleit, MD; Christophe A. Wyss, MD; Firat Duru, MD; Georg Noll, MD; Frank Ruschitzka, MD
A64-year-old man received 200 mg amiodarone QD for13 years because of intermittent atrial fibrillation. Dos-
age was increased to 200 mg TID because of persistent atrial
fibrillation in the fall of 2003. In October 2004, the patient
was first referred to our clinic because of tachycardic atrial
fibrillation and presented with a blue-gray discoloration of his
nose, cheeks, and lips, sparing the deep skin folds (Figure).
On a surface ECG, the corrected QT interval was 560 ms.
Ophthalmologic examination revealed vision impairment re-
sulting from corneal drug deposits. Within 1 month after
discontinuation of amiodarone the patient’s blue-gray discoloration
vanished, confirming the diagnosis of amiodarone-induced pigmen-
tation (ceruloderma). This typical appearance is due to deposition of
melanin and lipofuscin in the dermis and occurs in 1% to 3% of
patients on chronic amiodarone therapy, preferentially affecting
men. Patients are advised to avoid sun exposure, but no specific
therapy exists. Complete resolution may take up to a year or more.
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